AVIR

Atea Pharmaceuticals (AVIR)

About Atea Pharmaceuticals (AVIR)

Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.

Details

Daily high

$3.48

Daily low

$3.39

Price at open

$3.40

52 Week High

$4.60

52 Week Low

$2.76

Market cap

292.1M

Dividend yield

0.00%

Volume

121,430

Avg. volume

254,406

P/E ratio

-1.65

Atea Pharmaceuticals News